Philipp K. Haber

4.3k total citations · 2 hit papers
33 papers, 1.6k citations indexed

About

Philipp K. Haber is a scholar working on Surgery, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Philipp K. Haber has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 19 papers in Hepatology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Philipp K. Haber's work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Philipp K. Haber is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Philipp K. Haber collaborates with scholars based in Germany, United States and Spain. Philipp K. Haber's co-authors include Josep M. Llovet, Tim Meyer, Thierry de Baère, Laura Kulik, Riccardo Lencioni, Tim F. Greten, Daniela Sia, Moritz Schmelzle, Johann Pratschke and Parissa Tabrizian and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Philipp K. Haber

32 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

2021 633 citations Josep M. Llovet, Thierry de Baère et al. Nature Reviews Gastroenterology & Hepatology profile →
Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)

2021 165 citations Philipp K. Haber, Marc Puigvehí et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philipp K. Haber Germany	16	830	504	409	358	307	33	1.6k
Chia‐Jui Yen Taiwan	25	686 0.8×	663 1.3×	433 1.1×	236 0.7×	383 1.2×	139	1.8k
Akira Mitoro Japan	24	392 0.5×	352 0.7×	274 0.7×	345 1.0×	429 1.4×	103	1.9k
Zhongguo Zhou China	21	845 1.0×	489 1.0×	325 0.8×	353 1.0×	358 1.2×	87	1.7k
Sara Vander Borght Belgium	23	656 0.8×	604 1.2×	238 0.6×	614 1.7×	452 1.5×	50	1.8k
Yukio Iwashita Japan	20	478 0.6×	536 1.1×	289 0.7×	512 1.4×	298 1.0×	79	1.3k
Yinying Lu China	24	656 0.8×	432 0.9×	302 0.7×	284 0.8×	474 1.5×	99	1.8k
Ik Joo Chung South Korea	19	401 0.5×	352 0.7×	278 0.7×	231 0.6×	178 0.6×	57	1.4k
Atsushi Nanashima Japan	26	1.1k 1.3×	685 1.4×	758 1.9×	1.2k 3.3×	618 2.0×	210	2.6k
Kuang‐Liang King Taiwan	24	1.2k 1.4×	544 1.1×	440 1.1×	788 2.2×	661 2.2×	58	2.1k
Jieer Ying China	18	333 0.4×	850 1.7×	532 1.3×	430 1.2×	196 0.6×	95	1.7k

Countries citing papers authored by Philipp K. Haber

Since Specialization

Citations

This map shows the geographic impact of Philipp K. Haber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp K. Haber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp K. Haber more than expected).

Fields of papers citing papers by Philipp K. Haber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp K. Haber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp K. Haber. The network helps show where Philipp K. Haber may publish in the future.

Co-authorship network of co-authors of Philipp K. Haber

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp K. Haber. A scholar is included among the top collaborators of Philipp K. Haber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp K. Haber. Philipp K. Haber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haber, Philipp K., Felix Krenzien, Kaya Sarıbeyoğlu, Johann Pratschke, & Wenzel Schöning. (2024). Integrating the new systemic treatment landscape and surgical therapy in hepatocellular carcinoma. Turkish Journal of Surgery. 40(1). 1–10.

Özdirik, Burcin, et al.. (2023). Biliary microbial patterns in primary sclerosing cholangitis are linked to poorer transplant-free survival. Hepatology Communications. 7(6). 6 indexed citations

Feldbrügge, Linda, Felix Krenzien, Sebastian Knitter, et al.. (2022). Robotic Liver Surgery: Technical Advantages Over Laparoscopic Technique Based on Parameters of Surgical Complexity and Perioperative Outcomes. Journal of Laparoendoscopic & Advanced Surgical Techniques. 33(1). 56–62. 1 indexed citations

Torrens, Laura, Carla Montironi, Marc Puigvehí, et al.. (2021). Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma. Hepatology. 74(5). 2652–2669. 107 indexed citations

Haber, Philipp K., Christian Benzing, Felix Krenzien, et al.. (2021). Safety of intermittent Pringle maneuver during minimally invasive liver resection in patients with hepatocellular carcinoma with and without cirrhosis. Langenbeck s Archives of Surgery. 407(1). 235–244. 8 indexed citations

Haber, Philipp K., Marc Puigvehí, Florian Castet, et al.. (2021). Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020). Gastroenterology. 161(3). 879–898. 165 indexed citations breakdown →

Haber, Philipp K., Felix Krenzien, Simon Wabitsch, et al.. (2021). Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections. SHILAP Revista de lepidopterología. Volume 8. 133–143. 10 indexed citations

Haber, Philipp K., Miguel Torres‐Martín, Jean‐François Dufour, et al.. (2021). Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.. Journal of Clinical Oncology. 39(15_suppl). 4100–4100. 22 indexed citations

Llovet, Josep M., Thierry de Baère, Laura Kulik, et al.. (2021). Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology. 18(5). 293–313. 633 indexed citations breakdown →

10.

Haber, Philipp K., Simon Wabitsch, Andréas Andreou, et al.. (2020). Laparoscopic Liver Resection for Intrahepatic Cholangiocarcinoma: A Single-Center Experience. Journal of Laparoendoscopic & Advanced Surgical Techniques. 30(12). 1354–1359. 23 indexed citations

11.

Felden, Johann von, Amanda J. Craig, Teresa García‐Lezana, et al.. (2020). Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma. Oncogene. 40(1). 140–151. 99 indexed citations

12.

Wabitsch, Simon, Wenzel Schöning, Philipp K. Haber, et al.. (2020). A propensity-matched study of full laparoscopic versus hand-assisted minimal-invasive liver surgery. Surgical Endoscopy. 35(5). 2021–2028. 13 indexed citations

13.

Wabitsch, Simon, Philipp K. Haber, Christian Benzing, et al.. (2019). Laparoscopic Versus Open Liver Resection for Benign Tumors and Lesions: A Case Matched Study with Propensity Score Matching. Journal of Laparoendoscopic & Advanced Surgical Techniques. 29(12). 1518–1525. 12 indexed citations

14.

Wabitsch, Simon, Philipp K. Haber, Linda Feldbrügge, et al.. (2019). Laparoscopic versus open hemihepatectomy—a cost analysis after propensity score matching. Langenbeck s Archives of Surgery. 404(4). 469–475. 14 indexed citations

15.

Feldbrügge, Linda, Simon Wabitsch, Christian Benzing, et al.. (2019). Safety and feasibility of laparoscopic liver resection in patients with a history of abdominal surgeries. HPB. 22(8). 1191–1196. 16 indexed citations

16.

Haber, Philipp K., Simon Wabitsch, Felix Krenzien, et al.. (2018). Laparoscopic liver surgery in cirrhosis – Addressing lesions in posterosuperior segments. Surgical Oncology. 28. 140–144. 18 indexed citations

17.

Krenzien, Felix, Simon Wabitsch, Philipp K. Haber, et al.. (2018). Validity of the Iwate criteria for patients with hepatocellular carcinoma undergoing minimally invasive liver resection. Journal of Hepato-Biliary-Pancreatic Sciences. 25(9). 403–411. 46 indexed citations

18.

Maier, Christoph, Ines Schadock, Philipp K. Haber, et al.. (2017). Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II. Journal of Molecular Medicine. 95(5). 473–486. 31 indexed citations

19.

Röggla, Georg, et al.. (1993). A Rare Complication of a Central Venous Catheter System (Port-a-Cath^®). International Journal of Sports Medicine. 14(6). 345–346. 13 indexed citations

20.

Burghuber, Otto C., K Silberbauer, Philipp K. Haber, et al.. (1984). Pulmonary and Antiaggregatory Effects of Prostacyclin after Inhalation and Intravenous Infusion. Respiration. 45(4). 450–454. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact